Opportunity Information: Apply for PAR 19 374
Apply for PAR 19 374
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2019-09-13.
- Applicants must submit their applications by 2022-09-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) funding opportunity (PAR-19-374) is a National Institutes of Health (NIH) cooperative agreement designed to support large, ambitious, and tightly coordinated research efforts that address a single overarching question or theme in aging. The core idea is to fund projects that are too complex to be handled well by a single stand-alone study, meaning the application is expected to propose multiple interdependent components (often several research projects and shared cores) that work together in a deliberately integrated way. The goal is not just to run several related studies side-by-side, but to create a program where each component informs and strengthens the others and where the combined whole is greater than the sum of its parts. Because the FOA is labeled “Clinical Trial Optional,” applicants may propose studies that include clinical trials, but they are not required to do so; the mechanism can support either clinical trial or non-clinical trial designs, as long as the overall research program remains focused on important questions relevant to aging.
The U19 is issued as a cooperative agreement rather than a standard grant, which signals that NIH anticipates an active partnership role during the life of the award. In practice, this typically means there is substantial NIH programmatic involvement in areas like milestones, coordination expectations, governance, progress monitoring, and sometimes harmonization across sites or components. This structure is particularly suited to multidisciplinary, multi-lab, or multi-institutional teams that need formal coordination to manage shared resources, common protocols, integrated datasets, or linked aims that depend on each other’s outputs.
The opportunity is aimed at projects that bring together investigators from multiple disciplines, either within a single institution or through a consortium of institutions. The emphasis on integration implies applicants should be prepared to describe how the different scientific pieces connect: how data and methods will be shared, how findings from one component will guide another, how the program will be managed, and how the collective effort will answer the central aging-related question more effectively than separate awards could. Typical multi-component U19 structures in NIH contexts often include administrative coordination and shared resource cores (for example, data management, biostatistics, recruitment, biospecimen handling, imaging, or other specialized platforms), though the exact configuration depends on the scientific needs of the proposed program.
Eligibility for applicants is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants listed for this FOA include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations (both with and without 501(c)(3) IRS status, other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; eligible federal agencies; Indian/Native American Tribal Governments other than federally recognized; and U.S. territories or possessions. This breadth is consistent with the multidisciplinary and often community- or population-engaged nature of aging research, where strong partnerships and diverse institutional settings can be critical.
At the same time, the FOA places clear limits on foreign participation at the applicant and component levels. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply either. However, “foreign components” as defined by the NIH Grants Policy Statement are allowed, meaning a U.S. applicant may include certain international elements when they meet NIH’s definition and justification requirements (for example, specific activities or collaborations abroad that are necessary for the science), even though the primary applicant organization must remain U.S.-based and the structure cannot be a non-domestic applicant or a non-domestic component of a U.S. organization.
From an administrative standpoint, the opportunity is categorized as discretionary funding and uses the cooperative agreement funding instrument. It falls under the health activity category and is associated with CFDA number 93.866. The sponsoring agency is NIH. The opportunity record indicates an original closing date of 2022-09-25 and a creation date of 2019-09-13. The listing does not provide an award ceiling amount or the expected number of awards in the provided source data, so those details would normally need to be confirmed in the full FOA text or related NIH budget guidance for the specific receipt date.
Overall, this FOA is best suited for research teams that already have a strong central aging research question and can justify why answering it requires an integrated, multi-component structure with coordinated leadership, shared infrastructure, and tightly linked aims. The most competitive concepts under a U19 mechanism typically show clear synergy among components, rigorous coordination and governance plans, and a compelling argument that the cooperative, program-like design is essential to deliver meaningful advances in aging research.
FAQs: Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) - PAR-19-374
What is this funding opportunity?
This opportunity is the NIH "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)" FOA (PAR-19-374). It supports large, ambitious, tightly coordinated research programs in aging that address a single overarching question or theme through multiple integrated components.
What is the main purpose of the U19 mechanism in this FOA?
The U19 mechanism is intended for research that is too complex to be handled well by a single stand-alone study. Applications are expected to include multiple interdependent components that work together in a deliberately integrated way so the combined program produces more value than several separate, loosely related studies.
What does "multi-component" mean in this context?
"Multi-component" typically means the application proposes several linked research projects and, often, shared cores or resources that support those projects. The defining feature is that the parts are interdependent and designed to inform and strengthen one another.
What does "integrated" mean for a U19 application?
Integration means the components are intentionally connected. Applicants are expected to explain how data and methods will be shared, how results from one component will guide or support another, how shared infrastructure will be used, and how the overall program will answer the central aging-related question more effectively than separate awards could.
Is this opportunity only for projects that include clinical trials?
No. The FOA is labeled "Clinical Trial Optional," which means applicants may propose studies that include clinical trials, but a clinical trial is not required. Both clinical trial and non-clinical trial designs can be supported as long as the overall program is focused on important questions relevant to aging.
What does "cooperative agreement" mean, and how is it different from a standard grant?
This FOA uses a cooperative agreement (U19) rather than a standard grant, indicating that NIH anticipates an active partnership role during the award. This typically involves substantial NIH programmatic involvement in areas such as milestones, coordination expectations, governance, progress monitoring, and sometimes harmonization across sites or components.
What kinds of teams or collaborations is this FOA designed for?
This opportunity is particularly suited to multidisciplinary, multi-lab, or multi-institutional teams that need formal coordination to manage shared resources, common protocols, integrated datasets, or linked aims where one component depends on another's outputs.
Do projects need to be at a single institution, or can they be multi-institution consortia?
Projects may be organized within a single institution or through a consortium of institutions. The FOA emphasizes bringing together investigators from multiple disciplines, and it supports structures that require deliberate coordination across people, labs, and/or organizations.
What are examples of shared cores or resources that might appear in a typical U19 structure?
While the exact configuration should match the scientific needs of the proposed program, typical shared cores in NIH multi-component programs may include administrative coordination and shared resource cores such as data management, biostatistics, recruitment, biospecimen handling, imaging, or other specialized platforms.
What is the central scientific focus expected by this FOA?
The program should address a single overarching question or theme in aging. The emphasis is on designing a coordinated set of components that collectively answer that central question more effectively than separate stand-alone projects.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governmental entities. Eligible applicants listed include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status, other than institutions of higher education); for-profit organizations other than small businesses; and small businesses.
Are any additional organization types explicitly highlighted as eligible?
Yes. The FOA highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; eligible federal agencies; Indian/Native American Tribal Governments other than federally recognized; and U.S. territories or possessions.
Can a foreign (non-U.S.) organization apply as the main applicant?
No. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization.
Can a non-domestic component of a U.S. organization apply?
No. Non-domestic components of U.S. organizations are not eligible to apply either.
Are any international activities allowed at all?
Yes. "Foreign components" (as defined by the NIH Grants Policy Statement) are allowed. This means a U.S. applicant may include certain international elements when they meet NIH's definition and justification requirements, even though the primary applicant organization must be U.S.-based and cannot be a non-domestic applicant or non-domestic component.
What is the funding instrument and funding type?
The funding instrument is a cooperative agreement. The opportunity is categorized as discretionary funding.
What is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
What is the activity category for this opportunity?
The activity category is health.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.866.
What are the key dates provided for this opportunity?
The opportunity record indicates a creation date of 2019-09-13 and an original closing date of 2022-09-25.
Does the provided listing include an award ceiling or expected number of awards?
No. The provided source data does not include an award ceiling amount or the expected number of awards. Those details would typically be confirmed in the full FOA text or related NIH budget guidance for the specific receipt date.
What makes a concept a good fit for this FOA (based on the description provided)?
This FOA is best suited for teams that have a strong central aging research question and can justify why it requires an integrated, multi-component structure with coordinated leadership, shared infrastructure, and tightly linked aims. Competitive concepts typically emphasize clear synergy among components, rigorous coordination and governance plans, and a strong rationale for why a cooperative, program-like design is essential.
Browse more opportunities from the same category: Health
Next opportunity: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Previous opportunity: Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 374
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 374) also looked into and applied for these:
| Funding Opportunity |
|---|
| Innovative Programs to Enhance Research Training (IPERT) (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 19 383 Funding Number: PAR 19 383 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25) Apply for PAR 19 380 Funding Number: PAR 19 380 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Projects (Collaborative U01 - Clinical Trial Not Allowed) Apply for RFA AA 20 003 Funding Number: RFA AA 20 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trial Not Allowed) Apply for RFA AA 20 005 Funding Number: RFA AA 20 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trial Not Allowed) Apply for RFA AA 20 004 Funding Number: RFA AA 20 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 19 028 Funding Number: RFA OD 19 028 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| The President’s Malaria Initiative: Evaluation & Research-to-Use Implementation Project Apply for GH BAA 2018 ADDENDUM04 Funding Number: GH BAA 2018 ADDENDUM04 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required) Apply for RFA AG 20 051 Funding Number: RFA AG 20 051 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required) Apply for RFA AG 20 050 Funding Number: RFA AG 20 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed) Apply for PAR 20 027 Funding Number: PAR 20 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) Apply for PAR 20 026 Funding Number: PAR 20 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 19 390 Funding Number: PAR 19 390 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Delivery for Vulnerable Children and Adolescents (SDVCA) Apply for 72061120RFA00001 Funding Number: 72061120RFA00001 Agency: Zambia USAID-Lusaka Category: Health Funding Amount: $50,000,000 |
| Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18) Apply for PA 20 028 Funding Number: PA 20 028 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) Apply for PAR 20 029 Funding Number: PAR 20 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 065 Funding Number: RFA AI 19 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 059 Funding Number: RFA AI 19 059 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed) Apply for PAR 19 394 Funding Number: PAR 19 394 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) Apply for PAR 20 021 Funding Number: PAR 20 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Behavioral and Social Research LEaders in Alzheimers Disease and Its Related Dementias (NIA BSR LEADR) (DP1 - Clinical Trial Not Allowed) Apply for RFA AG 20 033 Funding Number: RFA AG 20 033 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 374", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
